Skip to main content
Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.160
-0.030 (-2.52%)
Apr 29, 2026, 11:32 AM EDT - Market open

Bionano Genomics Revenue

In the year 2025, Bionano Genomics had annual revenue of $28.51M, down -7.37%. Bionano Genomics had revenue of $7.95M in the quarter ending December 31, 2025, a decrease of -2.60%.

Revenue (ttm)
$28.51M
Revenue Growth
-7.37%
P/S Ratio
0.46
Revenue / Employee
$293,897
Employees
97
Market Cap
12.87M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202528.51M-2.27M-7.37%
Dec 31, 202430.78M-5.34M-14.79%
Dec 31, 202336.12M8.31M29.90%
Dec 31, 202227.80M9.82M54.62%
Dec 31, 202117.98M9.48M111.47%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Harvard Bioscience 86.55M
Retractable Technologies 38.27M
Jin Medical International 20.69M
Nephros 18.79M
Ekso Bionics Holdings 12.80M
NEXGEL 11.42M
Milestone Scientific 8.97M
Lucyd 2.66M
Revenue Rankings

BNGO News

More News